The Journal of Pharmacy and Bioallied Sciences is a premier open access publication that has been contributing to the fields of Pharmacy, Bioengineering, and Biochemistry since its establishment in India, under the esteemed Wolters Kluwer Medknow Publications. With the ISSN 0976-4879 and E-ISSN 0975-7406, this journal provides a platform for high-quality research articles, reviews, and clinical studies aimed at advancing knowledge and practice in the pharmaceutical and allied sciences. As a reflection of its academic stature, the journal holds a respectable categorization within the third and fourth quartiles in pertinent fields according to the latest metrics, with rankings that place it among prominent emerging research in pharmacology and biochemistry. Researchers and professionals are encouraged to access a wealth of knowledge freely, as the journal has been open access since 2010. The journal not only aims to foster innovative research but also strives to bridge the gap between pharmaceutical sciences and real-world applications, making it an essential resource for students, academics, and industry experts alike.

Pharmacy & Pharmacology-Farmatsiya i Farmakologiya is a distinguished journal published by the Pyatigorskii Mediko-Farmatsevticheskii Inst in the Russian Federation, dedicated to advancing research in the fields of pharmacy and pharmacology. Since its transition to an Open Access format in 2013, it has become an invaluable resource for researchers and professionals seeking to disseminate and access high-quality findings. With its ISSN 2307-9266 and E-ISSN 2413-2241, this journal covers a broad range of topics, providing a platform for the latest developments in pharmaceutical sciences. It is noteworthy that, as of 2023, Farmatsiya i Farmakologiya is categorized in various quartiles, with its Q2 ranking in Pharmacology (nursing) and Q3 in Pharmacy indicating its growing impact and relevance within its field. With the journal's commitment to fostering innovation and collaboration in pharmacy and pharmacology research, it serves as an essential hub for academics, practitioners, and students aiming to contribute to and stay informed about the dynamic landscape of this critical discipline.

The Future Journal of Pharmaceutical Sciences, published by Springer, stands as a vital resource in the realm of pharmaceutical research and innovation. Recognized for its open access initiative since 2015, this journal promotes extensive dissemination of cutting-edge discoveries, fostering collaboration among researchers, industry professionals, and students alike. With an ISSN of 2314-7245 and an E-ISSN of 2314-7253, it aims to bridge the gap between laboratory research and practical applications in the pharmaceutical sciences. Although specific metrics like HIndex and Scopus ranks are currently unavailable, the journal's commitment to high-quality, peer-reviewed content positions it as a promising platform for advancing pharmaceutical science. By engaging with this journal, contributors and readers can participate in the vibrant discourse shaping the future of drug development, therapeutic strategies, and healthcare solutions.

Istanbul Journal of Pharmacy, published by Istanbul University, Faculty of Pharmacy, is a pivotal platform dedicated to the advancement of pharmaceutical sciences and technology. This journal serves as a vital resource for researchers, professionals, and students alike, seeking to disseminate cutting-edge research, reviews, and innovative methodologies within the pharmaceutical discipline. With a commitment to open access, the journal aims to foster a collaborative environment that promotes information sharing and scholarly discourse. The Istanbul Journal of Pharmacy invites submissions that delve into diverse topics ranging from drug formulation to pharmacokinetics, ensuring that readers are equipped with the latest insights and discoveries in the field. This journal is positioned to enhance scientific communication within the pharmaceutical community and support the continuous evolution of pharmacy practice and education globally.

The Brazilian Journal of Pharmaceutical Sciences is a prestigious and peer-reviewed journal dedicated to disseminating significant research across the fields of Pharmacology, Toxicology, and Pharmaceutics. Published by UNIV SAO PAULO, CONJUNTO QUIMICAS, this journal has been an Open Access platform since 2009, making it accessible to a global audience, fostering collaboration and knowledge sharing among researchers and professionals. With an ISSN of 1984-8250 and an E-ISSN of 2175-9790, it holds a respectable Q3 ranking in these fields for 2023, indicating its contribution to the scientific community's understanding and advancement of pharmaceutical sciences. As it converges from 2009 to 2024, the journal continues to address emerging trends and critical topics in drug development, safety, and efficacy, positioning itself as an essential resource for students, researchers, and practitioners seeking to contribute to and stay informed about advancements in pharmacological research. With its publication address in São Paulo, Brazil, the journal serves as a key outlet for Brazilian and international scholars alike.

SAUDI PHARMACEUTICAL JOURNAL, published by Elsevier, stands as a pivotal platform for scholarly communication within the realm of pharmaceutical sciences and pharmacology. With a commendable Q2 ranking in both Pharmaceutical Science and Pharmacology for 2023, this journal reflects a strong commitment to advancing scientific understanding and innovation. Open Access since 2009, the journal ensures that cutting-edge research is readily accessible to researchers, professionals, and students around the globe, fostering collaboration and knowledge sharing. Based in the Netherlands, the journal covers a wide scope of topics, contributing to a cumulative understanding of drug development, therapeutic strategies, and pharmaceutical education. With a significant presence in Scopus rankings—#57 in Pharmaceutical Science and #116 in Pharmacology—SAUDI PHARMACEUTICAL JOURNAL is a trusted resource for high-quality research that shapes the future of pharmaceutical sciences.

Journal of Research in Pharmacy Practice, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, is a premier open-access journal dedicated to advancing the field of pharmaceutical sciences through rigorous research and innovative practices. Since its inception, the journal has aimed to bridge gaps between pharmacy practice and research, providing a platform for researchers, professionals, and students alike to disseminate their findings and insights. With a commitment to high-quality, peer-reviewed content, the journal covers a wide array of topics including clinical pharmacy, medication management, and healthcare policies, contributing to the enhancement of global healthcare practices. The journal is easily accessible online, having embraced an open-access model since 2012, ensuring that valuable research is freely available to all. Engaging with the Journal of Research in Pharmacy Practice not only facilitates knowledge exchange but also aids in the continuous evolution of pharmacy practice, emphasizing its critical role in healthcare delivery and patient outcomes.

Indonesian Journal of Pharmacy (ISSN: 2338-9486; E-ISSN: 2338-9427), published by UNIV GADJAH MADA, FAC FARMASI, stands as a significant platform for disseminating pioneering research in the field of pharmacy and pharmacology. Since its transition to an Open Access format in 2011, the journal has enhanced its visibility and accessibility, catering to a global audience of researchers, practitioners, and students. With a commendable Q3 category ranking in Pharmaceutical Science, Pharmacology, and Pharmacy for 2023, along with its respectable Scopus ranks, it provides valuable insights and advancements in the pharmaceutical sciences, particularly relevant to the Indonesian context and beyond. The journal not only supports the academic community but also contributes to the enhancement of healthcare practices through rigorous peer-reviewed publications. By fostering knowledge exchange and collaboration, the Indonesian Journal of Pharmacy aims to play a pivotal role in advancing research and development in pharmacy-related disciplines.

Pharmaceutical Sciences, an esteemed journal published by Tabriz University of Medical Sciences, Faculty of Pharmacy, serves as a crucial platform for the dissemination of pioneering research in the fields of pharmaceutical science, pharmacology, and toxicology. With an impact factor reflective of its substantial contribution to the scientific community, this open access journal has been accessible since 2012, ensuring that researchers, professionals, and students worldwide can engage with its rich content. Located in Iran, it has continually evolved, covering research from 2009 to 2024, and boasts impressive rankings in multiple Scopus categories, including Q3 in Pharmaceutical Science and Q2 in Pharmacology, Toxicology and Pharmaceutics. By bridging gaps between scientific inquiry and practical applications, Pharmaceutical Sciences is dedicated to advancing pharmaceutical knowledge and promoting innovative practices that address significant health challenges.

Pharmacy is a premier open-access journal published by MDPI, dedicated to advancing research in the dynamic field of pharmaceutical sciences. Since its inception in 2013, this journal has become a vital platform for disseminating novel findings, reviews, and insights related to drug development, pharmacokinetics, pharmaceutical technology, and clinical applications. With an E-ISSN of 2226-4787, Pharmacy prioritizes accessibility and visibility, allowing researchers, professionals, and students from around the globe to engage with cutting-edge research without barriers. The journal plays a crucial role in shaping pharmaceutical education and practice, fostering innovative ideas and collaborative approaches aimed at improving health outcomes. As part of the MDPI family, Pharmacy is committed to maintaining high-quality standards, ensuring that all published articles undergo rigorous peer review.